Fund size | GBP 2 m |
Total expense ratio | 0.30% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | GBP |
Currency risk | Currency hedged |
Volatility 1 year (in GBP) | 11.57% |
Inception/ Listing Date | 21 June 2017 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Luxembourg |
Fund Provider | UBS ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Bank International GmbH, Luxembourg Branch |
Investment Advisor | |
Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
Revision Company | Ernst & Young, société anonyme |
Fiscal Year End | 31 December |
Swiss representative | UBS Fund Management (Switzerland) AG |
Swiss paying agent | UBS Switzerland AG |
Germany | Tax transparent |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty | ABN AMRO Bank N.V.|Bank of Nova Scotia (London Branch)|Barclays Bank plc|Barclays Capital Securities Limited|BNP Paribas (London Branch)|BNP Paribas SA|Citigroup Global Markets Limited|Commerzbank AG|Commerzbank AG (London Branch)|Credit Suisse Securities (Europe) Limited|Deutsche Bank AG|Deutsche Bank AG (London Branch)|Goldman Sachs International|HSBC Bank plc|ING Bank N.V.|ING Bank N.V. (London Branch)|JP Morgan Securities PLC|MacQuarie Bank Ltd. (London Branch)|Merrill Lynch International|Morgan Stanley Morgan Stanley & Co. International plc|SEB AG (Frankfurt Branch)|Skandinaviska Enskilda Banken|Societe Generale SA|Societe Generale SA (London Branch)|State Street Bank International GmbH (London Branch) |
Novo Nordisk | 3.63% |
ASML Holding | 3.52% |
Nestle | 2.60% |
LVMH Moet Hennessy | 2.36% |
Novartis | 1.95% |
Shell | 1.90% |
SAP | 1.83% |
AstraZeneca | 1.83% |
Roche Holding | 1.73% |
Siemens | 1.41% |
YTD | +20.28% |
1 month | -1.39% |
3 months | +2.64% |
6 months | +5.61% |
1 year | +17.63% |
3 years | - |
5 years | - |
Since inception (MAX) | - |
2023 | -9.82% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 11.57% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 1.52 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | - |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | UBEU | UBEU LN UETFUBEU | UBEU.L IEUGBAINAV=SOLA | UBS AG |
SIX Swiss Exchange | GBP | EUGBA | EUGBA SW IEUGBA | EUGBA.S EUGBAGBPINAV=SOLA | UBS AG |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core MSCI Europe UCITS ETF EUR (Dist) | 7,473 | 0.12% p.a. | Distributing | Sampling |
Amundi Stoxx Europe 600 UCITS ETF Acc | 7,262 | 0.07% p.a. | Accumulating | Full replication |
iShares Core MSCI Europe UCITS ETF EUR (Acc) | 7,058 | 0.12% p.a. | Accumulating | Sampling |
iShares Core EURO STOXX 50 UCITS ETF EUR (Acc) | 4,251 | 0.10% p.a. | Accumulating | Full replication |
Xtrackers MSCI Europe UCITS ETF 1C | 3,927 | 0.12% p.a. | Accumulating | Full replication |